ClinicalTrials.govpublic full text
A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice
diabetes mellitus, type 1, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866428
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.